Site Announcement
Xenetic Biosciences and Santersus AG Announce Definitive Share Exchange Agreement to Create Global Leader in NET-Targeting Therapeutics
Corporate Headquarters
945 Concord Street
Framingham, MA 01701
Phone: 781-778-7720
info@xeneticbio.com
JTC Team, LLC.
Jenene Thomas
T: 908-824-0775
xbio@jtcir.com